2Goori n AM, Schwartzentruber D J, Devidas M,et al. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma:Pediatric Oncology Group Study POG-8651 [J]. J Clin Oncol, 2003,21 (8) : 1574-1580.
4Goorin AM, Schwartzentruber DJ, Devidas M, et al. Presur- gical chemotherapy compared with immediate surgery and ad- juvant chemotherapy for nonmetastatic osteosarcoma: Pediat- ric Oncology Group Study POG-8651[J]. J Clin Oncol, 2003, 21(8) : 1574-1580.
5Bielaek SS, Kempf-Bielack 13, Delling G, et al. Prognostic fac- tors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols[J]. J Clin Oncol, 2002,20 (3) :776-790.
6Link MP, Goorin AM, Miser AW, et al. The effect of adju- vant chemotherapy on relapse-free survival in patients with os- teosarcoma of the extremity[J]. N Engl J Med, 1986, 314 (25): 1600-1606.
7Enneking WF, Dunham W , Gebhardt MC, et al. A system for the functional evaluation of reconstructive pracedures after surgical treatment of tumors of the musculoskeletal system [J]. Clin Orthop Relat Res, 1993,286(1) : 241-246.
8Ligon AH, Potocki L, Shaffer LG, et al. Gene for multiple exostoses(EXT2) maps to 11(p11.2-12) and is deleted in patients with a contiguous gene deletion[J]. AM J Med Genet, 1998, 75(5): 538-540.
9Porter DE, Simpson AHRW. The neoplastic pathogenesis of solitary and multiple osteochondromas[J]. J Pathol, 1999, 188(2):119-125.
10Tarkkanen M, Elomaa I, Blomqvist C, et al. DNA sequence copy number increase at 8q: a potential new prognostic marker in high-grade osteosarcoma[J]. Int J Cancer, 1999, 84(2): 114-121.
